HPM Partners »

Agios Pharmaceuticals shares owned by HPM Partners

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by HPM Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $259k 6.4k 40.14
2025-06-30 $226k 6.8k 33.26

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corp Stock (MSFT)
iShares S&P 500 Index (IVV)
Spdr S&p 500 Etf (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Alphabet Stock (GOOGL)
Alphabet Stock (GOOG)
Ishares Tr Etf (QUAL)
Meta Platforms Stock (META)

View all positions for HPM Partners

Top funds holding Agios Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Erste Asset Management GmbH
Wellington Management Company
Commodore Capital
State Street Corporation
Caligan Partners
Macquarie Group
Armistice Capital
TCG Crossover Management
Geode Capital Management
Frazier Life Sciences Management

View all funds holding Agios Pharmaceuticals